Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Wormwood in Chronic Progressive Disorders With Reduced Appetite

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01126931
Recruitment Status : Unknown
Verified February 2008 by University Hospital Freiburg.
Recruitment status was:  Recruiting
First Posted : May 20, 2010
Last Update Posted : May 20, 2010
Sponsor:
Information provided by:
University Hospital Freiburg

Brief Summary:

Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer.

Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite


Condition or disease
Cancer

Detailed Description:

Supplementation with wormwood in chronic disorders associated with reduced appetite.

Examples:

  1. Cancer
  2. Autoimmune diseases such as Crohns disease and IgA Nephropathy
  3. Old age
  4. Chronic stress and depression

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Time Perspective: Prospective
Official Title: Pilot Trial With Wormwood to Improve Appetite in Cancer, Autoimmune Diseases, Depression and Old Age
Study Start Date : February 2006
Estimated Primary Completion Date : August 2012
Estimated Study Completion Date : December 2012

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Improvement in appetite [ Time Frame: 6-12 months ]

Secondary Outcome Measures :
  1. Improvement in quality of life [ Time Frame: 12-24 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient with reduced appetite and reduced quality of life as a result of chronic progressive disorders such as cancer, autoimmune diseases (Crohn, IgA-Nephropathy), old age and depression
Criteria

Inclusion Criteria:

  • Appetite and weight loss
  • Chronic progressive disease

Exclusion Criteria:

  • Life expectancy less than 3 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01126931


Contacts
Layout table for location contacts
Contact: Simone S Krebs, MD, Ph.D (+49) -761-27-3913 simone.krebs@uniklinik-freiburg.de

Locations
Layout table for location information
Germany
University of Freiburg, Medical Faculty Recruiting
Freiburg, Baden, Germany, 79110
Contact: Simone S Krebs, MD, PhD    (+49) -761-27-3913    simone.krebs@uniklinik-freiburg.de   
Principal Investigator: Simone S Krebs, MD, PhD         
Sponsors and Collaborators
University Hospital Freiburg
Investigators
Layout table for investigator information
Principal Investigator: Simone S Krebs, MD, PhD University of Freiburg, Nuclear Medicine, Germany
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Simone Krebs MD, Medical Faculty, University of Saarland, Homburg, Germany
ClinicalTrials.gov Identifier: NCT01126931    
Other Study ID Numbers: Appetite and Weight Loss
First Posted: May 20, 2010    Key Record Dates
Last Update Posted: May 20, 2010
Last Verified: February 2008
Keywords provided by University Hospital Freiburg:
Crohn disease
Involuntary weight loss in cancer
IgA nephropathy
Depression with reduced appetite